CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 452 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04017754
NCT04017754N/ACompleted

Low Plasma MBL Level is a Risk Factor for Recurrent Pregnancy Loss

Aalborg University Hospital·observational·Posted Jul 12, 2019·Updated Jul 30, 2021

In Brief

An observational study for Recurrent Miscarriage and 6 related conditions. Completed, enrolled 452 participants across 1 site.

Detailed Summary

The present study is based on the hypothesis, that recurrent pregnancy loss (RPL) is associated with abnormal plasma mannose binding lectin (p-MBL) level. Secondarily, p-MBL level may affect the reproductive and the perinatal outcome in the first pregnancy following RPL. Thus, the present study aim to examine whether MBL should be a biomarker for women at risk for RPL and, secondarily, affect the reproductive and perinatal outcome, and thereby help clinicians identify fragile women who need intensified perinatal care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 12, 2019
Enrollment StartJan 1, 2016
Primary CompletionMar 29, 2021
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 7.0 years ago